Consolidated Statements of Changes in Shareholders’ Equity |
Ordinary Shares
SGD ($)
shares
|
Ordinary Shares
USD ($)
shares
|
Additional paid-in capital
SGD ($)
|
Additional paid-in capital
USD ($)
|
Stock-based compensation reserve
SGD ($)
|
Stock-based compensation reserve
USD ($)
|
Accumulated other comprehensive income
SGD ($)
|
Accumulated other comprehensive income
USD ($)
|
Accumulated deficit
SGD ($)
|
Accumulated deficit
USD ($)
|
Non-controlling Interests
SGD ($)
|
Non-controlling Interests
USD ($)
|
SGD ($) |
USD ($) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at Dec. 31, 2024 | $ 32,229 | $ 29,044,790 | $ 537,756 | $ 96,416 | $ (22,936,714) | $ (475,138) | $ 6,299,339 | |||||||
| Balance (in Shares) at Dec. 31, 2024 | shares | 47,212 | 47,212 | ||||||||||||
| Issuance of new shares | $ 266,722 | 7,266,362 | 7,533,084 | |||||||||||
| Issuance of new shares (in Shares) | shares | 414,842 | 414,842 | ||||||||||||
| NET LOSS | (2,348,332) | (18,511) | (2,366,843) | |||||||||||
| Foreign currency translation adjustment | (59,193) | (59,193) | ||||||||||||
| Balance at Jun. 30, 2025 | $ 298,951 | 36,311,152 | 537,756 | 37,223 | (25,285,046) | (493,649) | 11,406,387 | |||||||
| Balance (in Shares) at Jun. 30, 2025 | shares | 462,054 | 462,054 | ||||||||||||
| Balance at Dec. 31, 2025 | $ 298,951 | 36,311,152 | 570,233 | (241,129) | (32,137,426) | (510,627) | 4,291,154 | |||||||
| Balance (in Shares) at Dec. 31, 2025 | shares | 462,054 | 462,054 | ||||||||||||
| NET LOSS | (1,775,172) | (66,448) | (1,841,620) | $ (1,422,872) | ||||||||||
| Foreign currency translation adjustment | 37,183 | 37,183 | ||||||||||||
| Disposal of subsidiaries | 790,164 | |||||||||||||
| Balance at Jun. 30, 2026 | $ 298,951 | $ 230,975 | $ 36,311,152 | $ 28,054,665 | $ 570,233 | $ 440,573 | $ 9,143 | $ 7,064 | $ (33,912,598) | $ (26,201,497) | $ 3,276,881 | $ 2,531,780 | ||
| Balance (in Shares) at Jun. 30, 2026 | shares | 462,054 | 462,054 |
| X | ||||||||||
- Definition Amount of disposal of subsidiaries. No definition available.
|
| X | ||||||||||
- Definition Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|